StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note released on Saturday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE AMPE opened at $0.08 on Friday. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $7.47. The stock has a 50 day moving average of $0.01 and a 200-day moving average of $0.06. The company has a market capitalization of $85,614.00, a P/E ratio of -0.01 and a beta of 3.73.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.